Objective: To study bone mineral content (BMC), bone mineral density (BMD), Vitamin D status and bone mineral parameters in subjects with chronic nonalcoholic pancreatitis and to determine the relationship between pancreatic dysfunction and these parameters.
INTRODUCTION:
Chronic Pancreatitis is a progressive condition in which permanent changes occur in the pancreas secondary to inflammation, leading to deficiency of pancreatic exocrine and endocrine functions (1) . Tropical pancreatitis, prevalent in developing countries, is a form of chronic calcific non-alcoholic pancreatitis in younger patients who present with steatorrhea and/or diabetes mellitus (2, 3) . Many patients have abdominal pain, weight loss, symptoms of maldigestion and diabetes but some have a paucity of symptoms. Functional tests for pancreatic insufficiency (4) in the early stages of pancreatitis are of limited utility and biopsy of the pancreas for the diagnosis of pancreatitis is impractical. Calcifications within the pancreatic ducts or parenchymaand/or dilated pancreatic ducts-combined with pancreatic atrophy are virtually pathagnomonic of chronic pancreatitis and occur in 90% of those with late stage disease (5, 6) .
In chronic pancreatitis, the chronic inflammation, low body mass index (BMI), undernutrition, co-existing diabetes, poor sunlight exposure and decreased physical activity due to chronic illness are factors that may increase the risk of bone loss.
Deficiency of fat-soluble vitamins is to be expected in patients with pancreatic insufficiency and steatorrhoea (1) . Vitamin D enhances calcium absorption, mineralization of osteoid and osteoblastic activity and vitamin D deficiency leads to reduced bone mineral density to an extent seen in osteopenia and osteoporosis before overt osteomalacia sets in. Osteoporosis leads to increased bone fragility and increases fracture frequency (7, 8) . There is limited knowledge about bone mineral status in chronic pancreatitis. In recent years a few groups have studied bone mineral density in chronic pancreatitis (9) (10) (11) . These studies with small numbers of patients show variable prevalence of metabolic bone disease and vitamin D deficiency. One of these studies (9) shows a significant positive correlation between 25(OH) vitamin D levels and BMD at lumbar spine and worsening BMD with increasing severity of chronic pancreatitis.
No prospective study so far has addressed the relative contribution of overall under nutrition, vitamin D deficiency, associated diabetes mellitus and the effect of chronic illness per se on the pathogenesis of pancreatic osteodystrophy. Long term studies on the fracture prevalence in these patients and the potential impact of interventions to improve bone health are unknown. With current treatment modalities patients with chronic pancreatitis with or without diabetes survive longer and awareness and early recognition of these skeletal problems may pave the way for interventional studies to improve bone health. The present study was therefore undertaken to assess the prevalence of osteoporosis in male subjects with non-alcoholic chronic pancreatitis and to evaluate potential contributing factors.
RESEARCH DESIGN AND METHODOLOGY:
Consecutive male patients aged between 20 and 60 years with proven chronic nonalcoholic pancreatitis attending the Endocrinology or Gastroenterology out-patient department were recruited (Fig. 1) . Women, men with history of alcohol dependence (12) , immobilized subjects, those with lower limb amputation, cardiovascular disease, liver disease, renal disease, hypogonadism and subjects on drugs affecting bone metabolism (hormones, anti-epileptics, anti-TB drugs, diuretics, glucocorticoids and anti-resorptive drugs) were excluded.
Clinical assessment included: (a) detailed history of abdominal pain, steatorrhea, weight loss, bone pain, fractures, complications of diabetes, drug history, concomitant illness, (b) assessment of dietary calcium intake using an oral semi-quantitative food frequency questionnaire (13, 14) , (c) examination to look for complications of diabetes, proximal myopathy, signs of malnutrition, hypocalcaemia and skeletal deformities.
Fasting serum calcium, phosphate, alkaline phosphatase, albumin, creatinine, plasma glucose,and 24 hour urinary calcium, phosphorous and creatinine were measured by a fully automated, micro analyzer (HITACHI 912). Serum 25 (OH) Vitamin D was measured by RIA (Dia Sorin, Stillwater Minnesota). Patients were maintained on a high-fat diet (50 g/day) for 5 days (starting 2 days before stool collection) and 72-hour stool fat was estimated. Stool fat excretion of ≥18 gms/day was considered abnormal (15) .
BMD was assessed by Hologic Machine DXA scanner (QDR 4500; Hologic, Inc, Waltham, MA, USA) at lumbar spine. We did not measure BMD at hip or forearm because of resource constraints. Daily calibration graphs were maintained using phantoms and the precision of measurement was 2%.The reference population was normal Caucasians (manufacturer's database).The results obtained in study subjects were compared with 35 subjects who were age and socioeconomic status matched normal lean male subjects without chronic pancreatitis or diabetes mellitus.
STATISTICAL ANALYSIS
The SPSS 11 software package was used. Pearson's correlation was used to study the relationship between normally distributed continuous variables. An independent Student's two-tailed t-test was used to compare the means of two continuous variables if they were normally distributed and nonparametric tests were used if their distribution was not normal.'P'-values < 0.05 was considered statistically significant. Linear regression was used to analyze the relationship between a dependent variable and one or more independent variables.
ETHICS
The study protocol was approved by the institutional review board. It conforms to the 
RESULTS:
A total of 31 males were studied (Fig 1) . The majority (91%) hailed from a middle class background, were gainfully employed and had unrestricted outdoor physical activity but sunlight exposure was not quantified in these subjects. All the patients had features of chronic pancreatitis documented either by ultrasonography, computed tomography or endoscopic retrograde cholangiopancreatography (ERCP). Eleven (35%) subjects had chronic pancreatitis of unknown etiology. Twenty subjects (65%)
had pancreatic duct dilatation with ductal calculi and parenchymal atrophy suggesting tropical fibrocalculous pancreatitis. Of these twenty subjects, eleven had diabetes (Fibrocalculous pancreatic diabetes). Some patients had irregular treatment with pancreatic enzymes in the past from other hospitals, but none of them had taken calcium and vitamin D supplements. The study subjects had not taken pancreatic enzymes for at least 3 months before presentation at our centre.
Abdominal pain and weight loss (50% of patients) were the most common symptoms.
The median duration of symptoms of abdominal pain and/or steatorrhea was 72 months (range 3-300 months p = 0.017) as has been described for normal subjects (17) .
When compared with the subjects having a normal T-score (Table 2) , those with T score < -2.5 were found to have a lower BMI (p = 0.021) and a trend towards higher stool fat excretion, but the 25(OH) Vitamin D levels were similar in the two groups.
Twenty one (68%) subjects had diabetes mellitus; of these 4 were on a diabetic diet, 4 were on oral diabetic agents and 13 subjects were on insulin. Four subjects had a family history of diabetes. The median duration of diabetes was 36 months (range 3 -204 In those with steatorrhea, the 25 (OH) vitamin D levels, BMI and BMD had a nonsignificant trend to be lower while BMC was significantly lower (Table 4) 
DISCUSSION:
Chronic pancreatitis with or without diabetes is a relatively common problem in India and other tropical countries (18, 19) . While it is well known that patients with Type 1 diabetes have a low bone mineral density (20) , BMD has not been extensively studied in chronic pancreatitis and associated diabetes mellitus. However there are a few reports which indicate that skeletal problems do occur in these patients.
The reported prevalence of low BMD (29%) in our subjects with chronic pancreatitis is nearly 1.5-2 times the prevalence of osteoporosis (14-19%) .This lack of correlation between BMD and 72 hour stool fat could be due to the inherent differences between these two parameters representing bone strength.
Even though the majority of studies have used Bone mineral density (BMD) for defining osteoporosis, areal bone mineral density does not take the volume of bone into consideration when assessing the bone strength. This would be a paradox as bone strength is related to bone volume also. Therefore Heaney (24) argues that studies assessing bone strength should present Bone mineral content (BMC).
Our study confirms that among patients with chronic pancreatitis, those with exocrine pancreatic deficiency and steatorrhea are a subgroup with the most severe reduction in BMC while those without steatorrhoea seem to be relatively protected. The significant inverse correlation between stool fat content and lumbar spine BMC in the entire group further strengthens our argument that chronic undernutrition is a major determinant of BMD and BMC in chronic pancreatitis. It is known that adipose tissue is an important source of estrogen in both sexes and it is possible that the lack of adipose tissue is partly responsible for the skeletal problem. These undernourished subjects have poor muscle mass as well and this could be an additional important contributing factor (25, 26) .
Depending on the criteria used to define Vitamin D deficiency, 64 % of our subjects with chronic pancreatitis had biochemical evidence of vitamin D insufficiency or deficiency. Our observation that patients with chronic pancreatitis and steatorrhoea have a lower mean 25(OH) vitamin D level is in agreement with the observations of Mann et al (9) . In our study nearly one fourth of subjects with chronic pancreatitis had severe vitamin D deficiency and overall the mean 25(OH) vitamin D level was significantly lower in the study subjects. However we were unable to find a significant correlation between 25(OH) vitamin D levels and BMD or BMC at the lumbar spine.
We did not measure BMD at femoral neck or distal radius. It is possible that low 25(OH) Vitamin D levels may be selectively related to BMD at these sites. Overall our findings imply that chronic overall malnutrition rather than selective vitamin D deficiency may be more important in the pathogenesis of pancreatic osteodystrophy.
Metabolic bone diseases are potentially treatable co-morbidities in chronic pancreatitis. With appropriate treatment for their diabetes and pancreatic malabsorption these patients live longer and are at risk for skeletal problems during their extended life-span. Paying critical attention to their nutrition and restoration of ideal body weight while maintaining optimal glycemic control may be of crucial importance in optimizing bone health in these subjects. Awareness of the magnitude of the skeletal problem in chronic pancreatitis and appropriate evaluation are important steps in the identification and management of patients at risk for pathological fractures.
We have studied only a small number of these subjects and prospective long-term studies in larger numbers of these patients with built in interventional strategies are warranted.
CONCLUSIONS:
1.Among male subjects with chronic non-alcoholic pancreatitis, at a mean age of 36
years, 29% had a T-score of < minus 2.5 and 32% had a T-score between minus 1 and minus 2.5. 
2.Compared

4.
In subjects with diabetes with chronic pancreatitis, there was a linear correlation between BMI and BMD but no correlation between 25 (OH) Vitamin D levels and BMD or BMC.
5.
Overall undernutrition in chronic pancreatitis rather than vitamin D deficiency may be an important determinant of BMD and BMC in these subjects.
6. Pancreatic osteodystrophy in chronic pancreatitis is an under recognized comorbidity requiring further study. 
